He added, “Therefore, I expect that this will be done on the second day of approval, that is, on the 11th or 12th of next December.”
It was a companyPfizerThe American and her German partnerBountechOn Friday, they announced that they had submitted a request to the US Food and Drug Administration to approve the emergency use of the Covid-19 vaccine.
The companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.
And they said that they will start shipping the doses immediately, knowing that Pfizer expected to have 50 million vaccine doses ready this year, a sufficient amount to protect 25 million people.
In the same context, the US Food and Drug Administration granted, on Saturday, emergency approval to use a treatment for Covid-19, which was developed by the biotechnology company “Regeneron”.
The approved drug was used to treat US President Donald Trump when he contracted Covid-19.
“France Press” quoted the official in the US Food and Drug Administration, Stephen Hahn, as saying that “allowing these treatments with monoclonal antibodies may allow patients to avoid hospitalization and reduce the burden on our health care system.”
For his part, CEO of Regeneron, Leonard Schleifer, said that this constitutes “an important step in the fight against Covid-19, as patients at high risk in the United States will be able to obtain a promising treatment early in the course of infection.”